Page last updated: 2024-09-03

2-(2,3-dicarboxycyclopropyl)glycine and mgs 0028

2-(2,3-dicarboxycyclopropyl)glycine has been researched along with mgs 0028 in 1 studies

Compound Research Comparison

Studies
(2-(2,3-dicarboxycyclopropyl)glycine)
Trials
(2-(2,3-dicarboxycyclopropyl)glycine)
Recent Studies (post-2010)
(2-(2,3-dicarboxycyclopropyl)glycine)
Studies
(mgs 0028)
Trials
(mgs 0028)
Recent Studies (post-2010) (mgs 0028)
14011004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanco-Urgoiti, J; Collado, I; Espinosa, JF; Johnson, BG; Kingston, AE; Mazón, A; Pedregal, C; Schoepp, DD; Wright, RA1

Other Studies

1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and mgs 0028

ArticleYear
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
    Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17

    Topics: Animals; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Cell Line; Cyclopropanes; Glycine; Ligands; Models, Molecular; Rats; Receptors, Metabotropic Glutamate; Reflex, Startle; Stereoisomerism

2002